Last reviewed · How we verify

NCT05125796

Analgesic Use for Pain Relief in Scorpion Sting

Completed NA Last updated 8 February 2024
What this trial tests

NA trial testing paracetamol in Scorpion Stings in 106 participants. Completed in 1 October 2021.

Timeline
1 September 2020
Primary endpoint
1 October 2021
1 October 2021

Quick facts

Lead sponsorAdiyaman University Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment106
Start date1 September 2020
Primary completion1 October 2021
Estimated completion1 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Adiyaman University Research Hospital

Who can join

Adults 18 to 100, any sex, with Scorpion Stings. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In scorpion stings, patients mostly apply with the complaint of pain. Emergency physicians need to relieve this pain quickly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of paracetamol

Trials testing the same drug.

Other Adiyaman University Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05125796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing